Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy

Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy Publisher Pubmed

Azizi G^{1, 2} ; Abolhassani H^{2, 3} ; Asgardoon MH² ; Shaghaghi S^{2, 4} ; Negahdari B⁵ ; Mohammadi J⁶ ; Rezaei N² ; Aghamohammadi A²

Show Affiliations

1. Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran
2. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Childrens Medical Center, Tehran University of Medical Sciences, Tehran, Iran
3. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
4. Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
5. School of Advanced Technologies in Medicine, Department of Medical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran
6. Department of Biomedical Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran

Source: Expert Review of Clinical Pharmacology Published:2016

Abstract

Immunoglobulin therapy has not only served as a lifesaving approach for the prevention and treatment of infections in primary and secondary immunodeficiency diseases, but has also been used as an immunomodulatory agent for autoimmune and inflammatory disorders and to provide passive immunity for some infectious diseases. Most of the adverse effects associated with immunoglobulin therapy are mild, transient and self-limiting. However, serious side effects also occur. Therefore, to minimize the adverse events of immunoglobulin therapy, specialist review of patient clinical status and immunoglobulin products, in addition to selection of appropriate treatment strategy for the management of patients with associated side effects and adverse events, are crucial. © 2015 Taylor & Francis.

Related Docs

View other Related Docs

1. Different Brands of Intravenous Immunoglobulin for Primary Immunodeficiencies: How to Choose the Best Option for the Patient?, Expert Review of Clinical Immunology (2015)

2. Agammaglobulinemia: Comorbidities and Long-Term Therapeutic Risks, Expert Opinion on Orphan Drugs (2017)

3. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases, Endocrine# Metabolic and Immune Disorders - Drug Targets (2016)

4. Adverse Reactions in a Large Cohort of Patients With Inborn Errors of Immunity Receiving Intravenous Immunoglobulin, Clinical Immunology (2021)

5. Cost-Effectiveness Analysis of Subcutaneous Immunoglobulin Replacement Therapy in Iranian Patients With Primary Immunodeficiencies, Medical Journal of the Islamic Republic of Iran (2017)

6. A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients With Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis, Expert Review of Clinical Immunology (2016)

7. Economic Burden of Common Variable Immunodeficiency: Annual Cost of Disease, Expert Review of Clinical Immunology (2015)

8. Measurement of Health-Related Quality of Life in Primary Antibody-Deficient Patients, Immunological Investigations (2017)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (11)

Leili Koochak Zadeh (1)

Style	Citing Format
MLA	Azizi G, et al.. "Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy." Expert Review of Clinical Pharmacology, vol. 9, no. 1, 2016, pp. 91-102.
APA	Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, Rezaei N, Aghamohammadi A (2016). Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy. Expert Review of Clinical Pharmacology, 9(1), 91-102.
Chicago	Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, Rezaei N, Aghamohammadi A. "Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy." Expert Review of Clinical Pharmacology 9, no. 1 (2016): 91-102.
Harvard	Azizi G et al. (2016) 'Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy', Expert Review of Clinical Pharmacology, 9(1), pp. 91-102.
Vancouver	Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, et al.. Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy. Expert Review of Clinical Pharmacology. 2016;9(1):91-102.
BibTex	@article{ author = {Azizi G and Abolhassani H and Asgardoon MH and Shaghaghi S and Negahdari B and Mohammadi J and Rezaei N and Aghamohammadi A}, title = {Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy}, journal = {Expert Review of Clinical Pharmacology}, volume = {9}, number = {1}, pages = {91-102}, year = {2016} }
RIS	TY - JOUR AU - Azizi G AU - Abolhassani H AU - Asgardoon MH AU - Shaghaghi S AU - Negahdari B AU - Mohammadi J AU - Rezaei N AU - Aghamohammadi A TI - Managing Patients With Side Effects and Adverse Events to Immunoglobulin Therapy JO - Expert Review of Clinical Pharmacology VL - 9 IS - 1 SP - 91 EP - 102 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract